ReviewJournal for immunotherapy of cancer2025
CAR-T cell therapy in older adults with relapsed/refractory LBCL: benefits and challenges.
Leyla Shune et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it